
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 79944-56-2 |
| Catalog No. | 2A-9010892 |
| Chinese Name | 盐酸咪唑克生 |
| Synonyms | Idazoxan Hydrochloride; Melanotan II; IdazoxanHCl |
| Molecular Formula | C11H13ClN2O2 |
| Molecular Weight | 240.69 |
| Purity | 98 |
| Boiling Point | 397ºC at 760 mmHg |
| Storage Condition | 2-8°C, sealed, dry |
| Application | Idazoxan hydrochloride (RX 781094 hydrochloride) is an α2-adrenergic receptor antagonist and an imidazoline receptor (IRs) antagonist that competitively antagonizes the central antihypertensive effect |
| PubChem ID | 24278493 |
| MDL Number | MFCD00069293 |
| SMILES | Cl.C1CN=C(N1)C2COc3ccccc3O2 |
| InChI | 1S/C11H12N2O2.ClH/c1-2-4-9-8(3-1)14-7-10(15-9)11-12-5-6-13-11;/h1-4,10H,5-7H2,(H,12,13);1H |
| InChI Key | MYUBYOVCLMEAOH-UHFFFAOYSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 12352200 |
| Hazard Symbols | Transport |
| MSDS | msds/10892_1_79944_56_2.pdf |
| Bioactivity | Idazoxan hydrochloride (RX 781094 hydrochloride) is an α2-adrenoceptor antagonist and is also a imidazoline receptors (IRs) antagonist competitively antagonized the centrally induced hypotensive effect of imidazoline-like drugs (IMs). Idazoxan hydrochloride also improves motor symptoms in Parkinson's disease, L-DOPA-induced dyskinesias, and experimental Parkinsonism[1][2]. Related Catalog Research Areas >> Endocrinology Target α2-adrenoceptor[1]; Imidazoline receptors (IRs)[2] In Vivo Idazoxan (0.16-5 mg/kg; subcutaneous injection; for 1 hour; male CD-COBS rats) treatment potently reverses haloperidol-induced catalepsy with an ED50 of 0.25 mg/kg. Idazoxan (0.3 and 2.5 mg/kg) has no effect on extracellular DA and do not modify the rise of extracellular DA induced by haloperidol[1]. Animal Model: Male CD-COBS rats injected with 1 mg/kg haloperidol[1] Dosage: 0.16 mg/kg, 0.31 mg/kg, 0.63 mg/kg, 1.25 mg/kg, 2.5 mg/kg, and 5.0 mg/kg Administration: Subcutaneous injection; for 1 hour Result: Potently reversed haloperidol-induced catalepsy with an ED50 of 0.25 mg/kg. References [1]. Roberto W Invernizzi, et al. The α2-Adrenoceptor Antagonist Idazoxan Reverses Catalepsy Induced by Haloperidol in Rats Independent of Striatal Dopamine Release: Role of Serotonergic Mechanisms. Neuropsychopharmacology volume 28, pages872-879 (2003). [2]. Bousquet P, et al. Participation of imidazoline receptors and alpha(2-)-adrenoceptors in the central hypotensive effects of imidazoline-like drugs. Ann N Y Acad Sci. 1999 Jun 21;881:272-8. Chemical & Physical Properties Boiling Point 397ºC at 760 mmHg Molecular Formula C11H13ClN2O2 Molecular Weight 240.68600 Flash Point 193.9ºC Exact Mass 240.06700 PSA 42.85000 LogP 1.39450 InChIKey MYUBYOVCLMEAOH-UHFFFAOYSA-N SMILES Cl.c1ccc2c(c1)OCC(C1=NCCN1)O2 |
| Use of | Idazoxan hydrochloride (RX 781094 hydrochloride) is an α2-adrenoceptor antagonist and is also a imidazoline receptors (IRs) antagonist competitively antagonized the centrally induced hypotensive effect of imidazoline-like drugs (IMs). Idazoxan hydrochloride also improves motor symptoms in Parkinson's disease, L-DOPA-induced dyskinesias, and experimental Parkinsonism[1][2]. Properties Articles36 Name Idazoxan hydrochloride,2-(1,4-Benzodioxan-2-yl)-2-imidazolinehydrochloride Synonym More Synonyms Idazoxan Hydrochloride Biological Activity Description Idazoxan hydrochloride (RX 781094 hydrochloride) is an α2-adrenoceptor antagonist and is also a imidazoline receptors (IRs) antagonist competitively antagonized the centrally induced hypotensive effect of imidazoline-like drugs (IMs). Idazoxan hydrochloride also improves motor symptoms in Parkinson's disease, L-DOPA-induced dyskinesias, and experimental Parkinsonism[1][2]. Related Catalog Research Areas >> Endocrinology α2-adrenoceptor[1]; Imidazoline receptors (IRs)[2] References [1]. Roberto W Invernizzi, et al. The α2-Adrenoceptor Antagonist Idazoxan Reverses Catalepsy Induced by Haloperidol in Rats Independent of Striatal Dopamine Release: Role of Serotonergic Mechanisms. Neuropsychopharmacology volume 28, pages872-879 (2003). [2]. Bousquet P, et al. Participation of imidazoline receptors and alpha(2-)-adrenoceptors in the central hypotensive effects of imidazoline-like drugs. Ann N Y Acad Sci. 1999 Jun 21;881:272-8. Chemical & Physical Properties Exact Mass 240.06700 PSA 42.85000 LogP 1.39450 InChIKey MYUBYOVCLMEAOH-UHFFFAOYSA-N |
| Transport Info | Shipping Name: UN |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Dangerous Regulations for land transport: 2811 International Dangerous Regulations for sea transport: 2811 International Dangerous Regulations for air transport: 2811 14.2 United Nations shipping name European Land Transport Dangerous Regulations: TOXIC SOLID, ORGANIC, N.O.S. (Idazoxan hydrochloride) IMDG Code: TOXIC SOLID, ORGANIC, N.O.S. (Idazoxan hydrochloride) International air transport hazard regulations: Toxic solid, organic, n.o.s. (Idazoxan hydrochloride) 14.3 Transport hazard categories European Land Transport Danger Regulations: 6.1 International Maritime Transport Danger Regulations: 6.1 International Air Transport Danger Regulations: 6.1 14.4 Package group European Land Transport Danger Regulations: III International Maritime Transport Danger Regulations: III International Air Transport Danger Regulations: III 14.5 Environmental hazards European Land Transport Danger Regulations: No International Maritime Danger Regulations International Air Transport Danger Regulations: No Marine pollutants (yes/no): No 14.6 Special reminder to users No data available |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Ibopamine | 66195-31-1 | 2A-9010882 |
| Ibutilide | 122647-31-8 | 2A-9010884 |
| Ichthammol | 8029-68-3 | 2A-9010886 |
| Icopezil | 145508-78-7 | 2A-9010887 |
| Idazoxan | 79944-58-4 | 2A-9010891 |
| Idebenone | 58186-27-9 | 2A-9010893 |
| Idoxifene | 116057-75-1 | 2A-9010894 |
| Idralfidine | 95668-38-5 | 2A-9010895 |
| Idrapril | 127420-24-0 | 2A-9010896 |
| Idropranolol | 27581-02-8 | 2A-9010897 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA